Accuracy of clinical diagnosis in tremulous parkinsonian patients: A blinded video study

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 81, Issue 11, 2010, Pages 1223-1228

  Bajaj, Nin P S ^a,b   Gontu, Vamsi ^b   Birchall, James ^b   Patterson, James ^c   Grosset, Donald G ^c   Lees, Andrew J ^d  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b DERBY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c SOUTHERN GENERAL HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; N OMEGA FLUORO PROPYL 2BETA CARBOMETHOXY 3BETA (4 IODOPHENYL) NORTROPANE I 123; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; BRADYKINESIA; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FOLLOW UP; HUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREMOR; TREMOR DOMINANT PARKINSON DISEASE;

DIAGNOSIS, DIFFERENTIAL; DYSTONIC DISORDERS; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HUMANS; HYPOKINESIA; PARKINSONIAN DISORDERS; REPRODUCIBILITY OF RESULTS; SINGLE-BLIND METHOD; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREMOR; TROPANES;

EID: 78649595711     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.193391     Document Type: Article

References (39)

1. Hughes AJ, Daniel SE, Lees AJ, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-4.
2. Hughes AJ, Daniel SE, Lees AJ, et al. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002;125:861-70.
3. Meara J, Bhowmick BK, Hobson P. Accuracy of diagnosis in patients with presumed Parkinson's disease. Age Ageing 1999;28:99-102.
4. Marek K, Jennings D, Seibyl J. Long-term follow-up of patients with scans without evidence of dopaminergic deficit (SWEDD) in the ELLDOPA study. Neurology 2005;64:A274.
5. Marshall VL, Patterson J, Grosset DG, et al. Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging. Nucl Med Commun 2006;27:933-7. (Pubitemid 44706887)
6. Ceravolo R, Antonini A, Volterrani D, et al. Dopamine transporter imaging study in parkinsonism occurring in fragile X premutation carriers. Neurology 2005;65:1971-3.
7. Choi IS. Parkinsonism after carbon monoxide poisoning. Eur Neurol 2002;48:30-3.
8. FitzGerald PM, Jankovic J. Lower body parkinsonism: evidence for vascular etiology. Mov Disord 1989;4:249-60. (Pubitemid 19183126)
9. Gaig C, Marti MJ, Tolosa E, et al. 123I-Ioflupane SPECT in the diagnosis of suspected psychogenic Parkinsonism. Mov Disord 2006;21:1994-8. (Pubitemid 44848954)
10. Lorberboym M, Treves TA, Djaldetti R, et al. [123I]-FP/CIT SPECT imaging for distinguishing drug-induced parkinsonism from Parkinson's disease. Mov Disord 2006;21:510-14.
11. Olanow CW. Manganese-induced parkinsonism and Parkinson's disease. Ann N Y Acad Sci 2004;1012:209-23.
12. Reuter I, Hu MT, Chaudhuri KR, et al. Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome. J Neurol Neurosurg Psychiatry 2000;68:238-41.
13. Salvati M, Frati A, Letizia C, et al. Parkinsonian syndrome in a patient with a pterional meningioma: case report and review of the literature. Clin Neurol Neurosurg 2000;102:243-5.
14. Stewart DA. NICE guideline for Parkinson's disease. Age Ageing 2007;36:240-2.
15. Deuschl G, Bain P, Brin M. Consensus statement of the Movement Disorder Society on Tremor. Ad Hoc scientific committee. Mov Disord 1998;13(Suppl l3):2-23.
16. Gibb WR, Lees AJ. The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol Appl Neurobiol 1989;15:27-44.
17. Schneider SA, Edwards MJ, Mir P, et al. Patients with adult-onset dystonic tremor resembling parkinsonian tremor have scans without evidence of dopaminergic deficit (SWEDDs). Mov Disord 2007;22:2210-15.
18. Munchau A, Schrag A, Chuang C, et al. Arm tremor in cervical dystonia differs from essential tremor and can be classified by onset age and spread of symptoms. Brain 2001;124:1765-76. (Pubitemid 32845438)
19. Sheehy MP, Marsden CD. Writers' crampda focal dystonia. Brain 1982;105(Pt 3):461-80.
20. Micheli S, Fernandez-Pardal M, Quesada P, et al. Variable onset of adult inherited focal dystonia: a problem for genetic studies. Mov Disord 1994;9:64-8. (Pubitemid 24022616)
21. Jankovic J, Schwartz KS, Ondo W. Re-emergent tremor of Parkinson's disease J Neurol Neurosurg Psychiatry 1999;67:646-50.
22. Catafau AM, Tolosa E. DaTSCAN clinically uncertain parkinsonian syndromes study group. Impact of dopamine transporter SPECT using 123I-Ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes. Mov Disord 2004;19:1175-82.
23. Ghaemi M, Raethjen J, Hilker R, et al. Monosymptomatic resting tremor and Parkinson's disease: a multitracer positron emission tomographic study. Mov Disord 2002;17:782-8.
24. Ceravolo R, Antonini A, Volterrani D, et al. Predictive value of nigrostriatal dysfunction in isolated tremor: a clinical and SPECT study. Mov Disord 2008;23:2049-54.
25. Benamer HT, Oertel WH, Patterson J, et al. Prospective study of presynaptic dopaminergic imaging in patients with mild parkinsonism and tremor disorders: part 1. Baseline and 3-month observations. Mov Disord 2003;18:977-84.
26. Louis ED, Levy G, Marder K, et al. Diagnosing Parkinson's disease using videotaped neurological examinations: validity and factors that contribute to incorrect diagnoses. Mov Disord 2002;17:513-17. (Pubitemid 36040964)
27. Broussolle E, Krack P, Goetz CG, et al. Contribution of Jules Froment to the study of parkinsonian rigidity. Mov Disord 2007;22:909-14.
28. Jennings DL, Seibyl JP, Marek K, et al. (123I) beta-CIT and single-photon emission computed tomographic imaging vs clinical evaluation in Parkinsonian syndrome: unmasking an early diagnosis. Arch Neurol 2004;61:1224-9.
29. Whone AL, Watts RL, Stoessl AJ, et al. Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study. Ann Neurol 2003;54:93-101. (Pubitemid 36764985)
30. Parkinson Study Group. Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson study group. JAMA 2000;284:1931-8.
31. Jain S, Lo SE, Louis ED. Common misdiagnosis of a common neurological disorder: how are we misdiagnosing essential tremor? Arch Neurol 2006;63:1100-4.
32. Richards M, Marder K, Mayeux R, et al. Interrater reliability of the unified Parkinson's Disease rating scale motor examination. Mov Disord 1994;9:89-91.
33. Couch JR. Dystonia and tremor in spasmodic torticollis. Adv Neurol 1976;14:245-58.
34. Brooks DJ, Playford ED, Ibanez V, et al. Isolated tremor and disruption of the nigrostriatal dopaminergic system: an 18F-dopa PET study. Neurology 1992;42:1554-60.
35. Bonifati V, Rohe CF, Breedveld GJ, et al. Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology 2005;65:87-95.
36. Khan NL, Graham E, Critchley P, et al. Parkin disease: a phenotypic study of a large case series. Brain 2003;126:1279-92.
37. LeWitt PA, Burns RS, Newman RP. Dystonia in untreated parkinsonism. Clin Neuropharmacol 1986;9:293-7.
38. Poewe WH, Lees AJ, Stern GM. Dystonia in Parkinson's disease: clinical and pharmacological features. Ann Neurol 1988;23:73-8.
39. Bain PG. Dystonic tremor presenting as parkinsonism: long-term follow-up of SWEDDs. Neurology 2009;72:1443-5.